Edesa Biotech (EDSA) Other Non-Current Assets (2013 - 2026)
Edesa Biotech (EDSA) recorded Other Non-Current Assets of $39,120 in fiscal Q3 2026 (quarter ended Jun 30, 2026), down 4.0% from $40,739 a year earlier.
Powered by 
Analysis
Edesa Biotech (EDSA) Other Non-Current Assets (2013 - 2026) Analysis & Trends
At the end of FY2025 (ended Sep 30, 2025), Edesa Biotech reported Other Non-Current Assets of $39,966, down 2.9% from FY2024.
- Annual Other Non-Current Assets has a three-year compound annual growth rate of -38.5% (FY2022 to FY2025).
- Across earlier fiscal years, Other Non-Current Assets came in at $41,151 in FY2024 (-76.3%), $173,490 in FY2023 (+1.2%) and $171,464 in FY2022.
- The fiscal Q3 2026 figure is the lowest quarterly Other Non-Current Assets since fiscal Q2 2025.
- On a year-over-year basis, Other Non-Current Assets rose in two of the last seven quarters, with an average decline of 23.1%.
- Peak year-over-year performance for Other Non-Current Assets in the last five years was growth of 4.8% in fiscal Q1 2026, against a decline of 78.2% in fiscal Q1 2025 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn | 7.48 Bn |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn | 15.10 Bn |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn | 10.73 Bn |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn | 19.60 Bn |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn | 5.93 Bn |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn | - |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn | 12.98 Bn |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn | 4.75 Bn |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn | 9.94 Bn |
| 10 | Edesa Biotech | 26.59 Mn | -18.95 Mn | - | 39,120.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 39,120.00 |
| Dec 31, 2025 | 40,572.00 |
| Sep 30, 2025 | 39,966.00 |
| Jun 30, 2025 | 40,739.00 |
| Mar 31, 2025 | 38,748.00 |
| Dec 31, 2024 | 38,698.00 |
| Sep 30, 2024 | 41,151.00 |
| Jun 30, 2024 | 40,661.00 |
| Mar 31, 2024 | 41,067.00 |
| Dec 31, 2023 | 177,731.00 |
| Sep 30, 2023 | 173,490.00 |
| Jun 30, 2023 | 177,825.00 |
| Mar 31, 2023 | 174,126.00 |
| Dec 31, 2022 | 173,891.00 |
| Sep 30, 2022 | 171,464.00 |
| Dec 31, 2019 | 116,611.00 |
| Jun 30, 2019 | 15,340.00 |
| Mar 31, 2019 | 15,340.00 |
| Sep 30, 2018 | 15,340.00 |
| Jun 30, 2018 | 15,340.00 |
API Access
Edesa Biotech Other Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=EDSA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-assets", "ticker": "EDSA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=EDSA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();